Close Menu

intellectual property

NEW YORK (GenomeWeb) – Illumina announced after the close of the market on Friday that it is suing Ariosa Diagnostics for alleged patent infringement.

NEW YORK (GenomeWeb News) – Sequenom said in a regulatory filing today that the US Patent and Trademark Office, Patent Trial and Appeal Board has made rulings favorable to the company in an ongoing dispute with Verinata Health regarding noninvasive prenatal testing technologies.

Title: MADS Gene Regulatory Sequences for Expressing Gene Products in Plant Reproductive Tissue
Patent Number: 8,679,844

Title: Determinants of Sensitivity to Chemotherapeutic Agents
Patent Number: 8,673,869
Filed: Dec. 14, 2005

Title: Bacterially Derived Intact Minicells That Encompass Plasmid-free Functional Nucleic Acid for In Vivo Delivery to Mammalian Cells

Title: siRNA Compositions and Methods for Potently Inhibiting Viral Infection
Patent Number: 8,664,188
Filed: Dec. 11, 2009

Title: Polyconjugates for In Vivo Delivery of Polynucleotides
Patent Number: 8,658,211
Filed: Feb. 8, 2012

Title: Prevention of Chlamydia Infection using siRNA
Patent Number: 8,648,052
Filed: Oct. 8, 2007

Title: Lipid-containing Formulations
Patent Number: 8,642,076
Filed: Aug. 16, 2011

Title: Apoptotic Cell-mediated Transfection of Mammalian Cells with Interfering RNA
Patent Number: 8,637,476

Pages

The US Patent and Trademark Office is opening another interference proceeding in the CRISPR patent fight.

There's increasing genetic evidence that a number of ancient hominins may have contributed to the human gene pool, according to Discover's The Crux blog.

The Japan News writes that Japan needs to seize the opportunity to ensure that a wide number of people benefit from personalized cancer treatments.

In Cell this week: messenger RNA expression and translation, RNA localization atlas, and more.